Press release
Gastrointestinal Cancer Market Outlook Highlights Strategic Opportunities Across The Industry
Gastrointestinal Cancer Market
Projected Growth of the Gastrointestinal Cancer Market by 2030
The gastrointestinal cancer market is anticipated to experience significant expansion, reaching a valuation of $47.4 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 11.8% during the forecast period. Factors contributing to this robust increase include heightened investments in personalized oncology, wider adoption of biomarker-based diagnostics, the broadening pipeline of immuno-oncology treatments, growing use of minimally invasive diagnostic methods, and increased healthcare spending dedicated to cancer care. Key trends driving the market include the rising utilization of targeted gastrointestinal cancer therapies, a stronger emphasis on molecular diagnostics, the advancement of combination immunotherapy approaches, expansion of early screening programs, and deeper integration of precision medicine into treatment protocols.
The gastrointestinal cancer market size has grown rapidly in recent years. It will grow from $27.05 billion in 2025 to $30.33 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing prevalence of gastrointestinal cancers, expansion of diagnostic imaging capabilities, rising awareness of early cancer detection, growth in oncology drug development, improved access to cancer treatment facilities.
Download a free sample of the gastrointestinal cancer market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24546&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Top Companies Leading the Gastrointestinal Cancer Market
Several prominent corporations play an influential role in shaping the gastrointestinal cancer market, including Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Ipsen Biopharmaceuticals Inc., Exelixis Inc., BeiGene Ltd., Boehringer Ingelheim International GmbH, Zai Lab Limited, and Taiho Pharmaceutical Co. Ltd.
Strengthening Precision Medicine Capabilities Through Strategic Acquisitions
In February 2025, GSK plc, a UK-based pharmaceutical and biotechnology firm, completed the acquisition of IDRx Inc. for around $1.15 billion. This move is designed to bolster GSK's immunology and infectious disease pipelines, accelerate the development of cutting-edge therapies, and enhance its precision medicine capabilities aimed at addressing unmet medical needs. IDRx Inc., headquartered in the United States, is a clinical-stage biopharmaceutical company focused on creating precision therapeutics for gastrointestinal stromal tumors (GIST).
View the full gastrointestinal cancer market report:
https://www.thebusinessresearchcompany.com/report/gastrointestinal-cancer-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Key Innovations and Trends Shaping the Future of the Gastrointestinal Cancer Market
Leading companies in the gastrointestinal cancer arena are prioritizing the development of advanced treatments, such as monoclonal antibody therapies, which target cancer cells more effectively and aim to improve survival rates while reducing side effects. Monoclonal antibodies are lab-produced molecules designed to bind specifically to cancer cells, helping the immune system recognize and eliminate them. For example, in September 2024, Japan-based Astellas Pharma Inc. introduced VYLOY (zolbetuximab) in combination with fluoropyrimidine- and platinum-based chemotherapy. This treatment received approval from the European Commission as a first-line option for adults with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma expressing the biomarker claudin 18.2 (CLDN18.2). VYLOY is notable for being the first therapy in the European Union to target CLDN18.2, which is present in approximately 38% of patients within this group, following encouraging results from clinical trials SPOTLIGHT and GLOW.
Detailed Segmentation of the Gastrointestinal Cancer Market
The gastrointestinal cancer market is divided into several comprehensive segments:
1) Cancer Type: including colorectal cancer, stomach cancer, esophageal cancer, pancreatic cancer, liver cancer, and other types
2) Diagnostics: covering endoscopy, biopsy, molecular diagnostics, imaging, and other diagnostic approaches
3) Treatment: consisting of chemotherapy, immunotherapy, targeted therapy, radiation therapy, surgery, and additional treatment options
4) End-User: encompassing hospitals, oncology centers, research institutes, diagnostic laboratories, and other users
Further breakdowns include:
- Colorectal Cancer: colon cancer, rectal cancer, recurrent colorectal cancer, metastatic colorectal cancer
- Stomach Cancer: adenocarcinoma, gastrointestinal stromal tumors (GIST), lymphoma, carcinoid tumors
- Esophageal Cancer: adenocarcinoma, squamous cell carcinoma, small cell carcinoma, other rare esophageal tumors
- Pancreatic Cancer: exocrine pancreatic cancer, endocrine (neuroendocrine) pancreatic tumors, metastatic pancreatic cancer, resectable or unresectable tumors
- Liver Cancer: hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma, hepatoblastoma, secondary (metastatic) liver cancer
- Other Cancer Types: small intestine cancer, anal cancer, gallbladder cancer, gastrointestinal carcinoid tumor
This segmentation allows for a thorough understanding of the diverse elements shaping the gastrointestinal cancer market's development and future potential.
What's new in our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastrointestinal Cancer Market Outlook Highlights Strategic Opportunities Across The Industry here
News-ID: 4607462 • Views: …
More Releases from The Business Research Company
Fecal Incontinence Market Report Provides Insights Into Market Evolution And Gro …
The fecal incontinence market is positioned for substantial growth over the coming years, driven by advancements in treatment options and increasing patient awareness. As healthcare providers and patients alike seek more effective and less invasive solutions, the market is evolving rapidly. Below is a detailed overview of the market size, key players, emerging trends, and segmentation that are shaping this sector.
Projected Expansion and Market Value in the Fecal Incontinence Market…
Genomics Services Market Study Highlights How Industry Demand Is Evolving
The genomics services market is on the cusp of significant expansion, driven by advances in technology and increasing integration into healthcare and research sectors. As personalized medicine and genomic applications become more widespread, this sector is set to achieve remarkable growth within the coming years. Let's explore the market's expected valuation, key players, emerging trends, and the segments that define this industry.
Projected Growth and Market Value of the Genomics Services…
Genomic Selection Platform Market Research Reveals Strong 16.8% CAGR Outlook Thr …
The genomic selection platform industry is on the cusp of significant expansion, driven by technological innovations and increasing demand in agriculture and biotechnology. With advancements in genomics and data analytics, this sector is set to transform breeding programs and sustainable development efforts in the coming years. Let's explore the current market valuation, influential players, key trends, and segment breakdown within this rapidly evolving industry.
Projected Growth and Market Size of the…
Genome Editing/Genome Engineering Market Report Provides Insights Into Market Ev …
The genome editing and genome engineering market is on track for remarkable expansion, driven by technological advancements and growing applications across medicine and agriculture. This sector is becoming increasingly vital as researchers and companies push the boundaries of gene modification to address a wide range of health and scientific challenges. Let's explore the market's valuation forecast, major players, current trends, and key segments shaping its future.
Projected Market Valuation and Growth…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
